135 related articles for article (PubMed ID: 3856629)
1. The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients.
Beving H; Bjerkenstedt L; Malmgren R; Olsson P; Unge G
J Neural Transm; 1985; 61(1-2):95-104. PubMed ID: 3856629
[TBL] [Abstract][Full Text] [Related]
2. Methodological aspects of studies on the 5-HT uptake mechanism in normal platelets.
Malmgren R
Acta Pharmacol Toxicol (Copenh); 1981 Oct; 49(4):277-84. PubMed ID: 7342688
[TBL] [Abstract][Full Text] [Related]
3. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
Gottlieb P; Wandall T; Overø KF
Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram.
Fisar Z; Kalisová L; Paclt I; Anders M; Vevera J
Psychiatry Res; 2008 Nov; 161(2):185-94. PubMed ID: 18817980
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
[TBL] [Abstract][Full Text] [Related]
7. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.
Pedersen OL; Kragh-Sørensen P; Bjerre M; Overø KF; Gram LF
Psychopharmacology (Berl); 1982; 77(3):199-204. PubMed ID: 6812140
[TBL] [Abstract][Full Text] [Related]
8. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
Gastpar M; Gastpar G
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
Hyttel J
Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
[TBL] [Abstract][Full Text] [Related]
10. Citalopram--a highly selective 5-HT uptake inhibitor--in the treatment of depressed patients.
Dufour H; Bouchacourt M; Thermoz P; Viala A; Phak Rop P; Gouezo F; Durand A; Høpfner Petersen HE
Int Clin Psychopharmacol; 1987 Jul; 2(3):225-37. PubMed ID: 3320186
[TBL] [Abstract][Full Text] [Related]
11. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
Hyttel J
Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
[TBL] [Abstract][Full Text] [Related]
12. Increased serotonin platelet uptake after tianeptine administration in depressed patients.
Chamba G; Lemoine P; Flachaire E; Ferry N; Quincy C; Sassard J; Ferber C; Mocaër E; Kamoun A; Renaud B
Biol Psychiatry; 1991 Sep; 30(6):609-17. PubMed ID: 1932408
[TBL] [Abstract][Full Text] [Related]
13. Defective serotonin (5-HT) transport mechanism in platelets from patients with endogenous and allergic asthma.
Malmgren R; Grubbström J; Olsson P; Theorell H; Tornling G; Unge G
Allergy; 1982 Jan; 37(1):29-39. PubMed ID: 7137519
[TBL] [Abstract][Full Text] [Related]
14. Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls.
Arora RC; Meltzer HY
Psychiatry Res; 1983 May; 9(1):29-36. PubMed ID: 6577482
[TBL] [Abstract][Full Text] [Related]
15. Platelet serotonin content and uptake in spontaneously hypertensive rats.
Guicheney P; Legros M; Marcel D; Kamal L; Meyer P
Life Sci; 1985 Feb; 36(7):679-85. PubMed ID: 3968983
[TBL] [Abstract][Full Text] [Related]
16. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
[TBL] [Abstract][Full Text] [Related]
17. Effects of different anticoagulants on human platelet size distribution and serotonin (5-HT) induced shape change and uptake kinetics.
Malmgren R; Beving H; Olsson P
Thromb Res; 1985 Jun; 38(6):649-61. PubMed ID: 3927509
[TBL] [Abstract][Full Text] [Related]
18. [Citalopram. An open study of a highly selective serotonin-uptake inhibitor administered by infusion to depressive patients].
Charbonnier JF; Reboul P; Rougier M; Aubin B; Chassaing JL; Philippe P; Planche R; Hoepfner Petersen HE
Encephale; 1987; 13(4):249-54. PubMed ID: 3311709
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake.
Franke L; Schewe HJ; Müller B; Campman V; Kitzrow W; Uebelhack R; Berghöfer A; Müller-Oerlinghausen B
Life Sci; 2000 Jun; 67(3):301-15. PubMed ID: 10983874
[TBL] [Abstract][Full Text] [Related]
20. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
